Zhifei Biology (300122.SZ): Freeze-dried human rabies vaccine (ZFB-3 cells) receives clinical trial approval notice

Zhitong Finance APP News, Zhifei Biological (300122.SZ) announced that the company recently learned that the freeze-dried human rabies vaccine (ZFB-3 cells) developed by its wholly-owned subsidiary Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. ("Zhifei Longcom") has received a Drug Clinical Trial Approval Notice from the National Medical Products Administration (Notice No.: 2026LP03473), agreeing to conduct clinical trials for the prevention of rabies.